Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
The methodology of the fenclofenac clinical research programme and results obtained with particular reference to the therapeutic dose range.

Proceedings of the Royal Society of Medicine

Tudor R, Goldberg AA, Clarke DR.
PMID: 20919358
Proc R Soc Med. 1977;70:11-5.

No abstract available.

Therapeutic dose range of fenclofenac.

Proceedings of the Royal Society of Medicine

Lambert JR, Wright V.
PMID: 20919359
Proc R Soc Med. 1977;70:16-7.

No abstract available.

The Use of Quantitative Thermography to Assess the Anti-inflammatory Dose Range for Fenclofenac.

Proceedings of the Royal Society of Medicine

Bacon PA, Davies J, Ring EF.
PMID: 20919360
Proc R Soc Med. 1977;70:18-9.

No abstract available.

Fenclofenac in rheumatoid arthritis-comparative studies.

Proceedings of the Royal Society of Medicine

Loebl WY.
PMID: 20919364
Proc R Soc Med. 1977;70:31-3.

No abstract available.

Fenclofenac tolerance in the dyspeptic patient.

Proceedings of the Royal Society of Medicine

Salmon PR, O'Driscoll SL, Fedail S, Jayson MI.
PMID: 20919371
Proc R Soc Med. 1977;70:49-50.1.

No abstract available.

Preliminary clinical evaluation of fenclofenac (32 patients).

Proceedings of the Royal Society of Medicine

Glick EN.
PMID: 20919369
Proc R Soc Med. 1977;70:43-5.

No abstract available.

Analysis of the Side-effect Patterns Presenting During the Course of a Continuing Long-term Open Study of Fenclofenac.

Proceedings of the Royal Society of Medicine

Smith RB.
PMID: 20919370
Proc R Soc Med. 1977;70:46-8.

No abstract available.

Alterations in hepatocyte uptake and plasma binding of thyroxine in nonthyroidal illness and caloric deprivation.

Trends in endocrinology and metabolism: TEM

Lim CF, Stockigt JR, Hennemann G.
PMID: 18406679
Trends Endocrinol Metab. 1995 Jan-Feb;6(1):17-20. doi: 10.1016/1043-2760(94)00095-l.

Low plasma T(3) in severe illness is widely thought to be due principally to inhibition of 5'-deiodinase activity, but other factors also contribute to this response. Abnormal plasma constituents, namely, 3-carboxy-4-methyl-5-propyl-2-furan propanoic acid (CMPF) and indoxyl sulfate in uremia,...

Pharmacology and toxicology of fenclofenac.

Proceedings of the Royal Society of Medicine

Atkinson DC, Green D, Leach EC.
PMID: 20919357
Proc R Soc Med. 1977;70:1-3.

No abstract available.

Fenclofenac in Rheumatoid Arthritis: Sequential Double-blind Cross-over Comparisons with Placebo and Naproxen.

Proceedings of the Royal Society of Medicine

Pritchard MH, Evans PH, Nuki G.
PMID: 20919362
Proc R Soc Med. 1977;70:23-6.

No abstract available.

Fenclofenac and soluble aspirin in rheumatoid arthritis: a comparative trial.

Proceedings of the Royal Society of Medicine

Hill HF, Hill AG.
PMID: 20919363
Proc R Soc Med. 1977;70:27-30.

No abstract available.

Studies on the Anti-inflammatory Effects of Fenclofenac Using 99-Technetium Joint Scanning.

Proceedings of the Royal Society of Medicine

Rooney PJ, McLeod M, Madkour M, Mavrikakis M.
PMID: 20919361
Proc R Soc Med. 1977;70:20-2.

No abstract available.

Showing 1 to 12 of 17 entries